InvestInMJ Admin

Tweed, one of Canada's first medical cannabis producers, recently renamed Canopy Growth Corporation, has opened a dispensary in Guelph. The storefront now known as Better by Tweed, opened Oct. 15 and is the town’s first dispensary.

In September, Tweed purchased MedCannAccess a company focused on helping new medical marijuana patients and acquired the group’s three community access centres in Guelph, Hamilton and the Greater Toronto Area. The Hamilton location opened earlier in the week and Better by Tweed will soon expand with the Etobicoke Better Centre. 

The MedCannAccess locations had helped cannabis patients register with a licensed producer.

The Better by Tweed operation will provide patients with information packages to bring to their doctors to fill out and then return to the store where they can place orders for cannabis from Tweed’s production facilities in Smiths Falls, Toronto and Niagara-on-the-Lake.

“There will always be a market for medical marijuana, and, if the time comes, we’re well equipped for recreational use as well,” said Tweed president Mark Zekulin.

A historic deal between the Suquamish Tribe and the State of Washington was recently signed and entered into.  It allows a Native American Tribe to cultivate, process, and sell marijuana within a state’s highly regulated marijuana system.  While the Tribe’s own marijuana regulations have not been disclosed to the public, this does set a precedence and we expect more Native American tribes will follow suite in various States around the US and in other countries like Canada.

The Washington State Liquor and Cannabis Board negotiated the compact with the Suquamish Tribe on behalf of the state. In the compact, the state gives its own interpretation of the Wilkinson statement, writing that “[t]hat memo effectively treats tribal governments the same as state governments in the decision to legalize marijuana.”

Hilary Bricken’s provides her analysis, “The Suquamish Marijuana Compact: First in the State, First in the Nation”:  http://www.cannalawblog.com/the-suquamish-marijuana-compact-first-in-the-state-first-in-the-nation/

MassRoots, Inc. (MSRT), one of the largest and fastest growing social networks for cannabis consumers, is pleased to announce it has filed an application to become one of the first cannabis technology companies listed on the NASDAQ Capital Market. Last year, MassRoots was one of the first cannabis-related companies to go public through a Registration Statement on Form S-1, as opposed to a reverse-merger.

MassRoots has demonstrated tremendous growth in recent quarters, more than doubling its userbase since the beginning of 2015 to a half million users. The Company recently started monetizing its digital properties and is expecting to rapidly scale its revenues over the next several quarters. Sitting at the intersection of cannabis and mobile technology, MassRoots offers a direct play on the regulated marijuana industry without ever touching the plant itself.

“Uplisting to the NASDAQ Capital Market would be a significant milestone not just for MassRoots, but the cannabis industry as a whole,” stated MassRoots Chief Executive Officer Isaac Dietrich. “We believe that uplisting to a national exchange like the NASDAQ would enable MassRoots to attract a broader range of institutional investors, increase share liquidity and help shift the paradigm about investing in the regulated marijuana market.”

Kelowna, BC / August 24, 2015 / Lexaria, Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company”) is very pleased to announce potential industry-changing achievements in enhanced gastro-intestinal absorption of cannabidiol (CBD) utilizing Lexaria’s patent pending technology. The recent thirdparty testing was conducted in two phases of in vitro tests beginning in June and completed in August, 2015.

The independent laboratory results have delivered average CBD permeability of 499% of baseline permeability, compared to CBD permeability without Lexaria’s technology. These results exceed Company expectations.

This was assessed in a strictly controlled, in vitro experiment using a human intestinal tissue model. Samples of Lexaria’s commercially available CBD-fortified ViPova™ black tea were administered in the model compared with concentration-matched CBD control preparations that lacked Lexaria’s patent-pending formulation and process enhancements. Lexaria believes that its in vitro findings provide compelling evidence of the intestinal absorption enhancing capabilities of its technology, based on which it is exploring opportunities to progress to more advanced, follow-on bioavailability testing in animals.

SMITHS FALLS, ON, July 8, 2015 /CNW/ - Tweed Marijuana Inc. ("TMI" or "the Company"), parent company of Tweed Inc. ("Tweed") and Tweed Farms Inc. ("Tweed Farms") is pleased to announce that pursuant to notification received today from Health Canada, licensed producers such as Tweed and Tweed Farms will be eligible to produce and sell cannabis oils pending the necessary inspections and approvals from Health Canada.

Until today the Marihuana for Medical Purposes Regulations (MMPR) only allowed for the sale of dried cannabis flower. With the addition of cannabis oils to the regulatory framework, Tweed will be able to significantly increase its product offering to provide a more diverse variety for practitioners and patients.

"This is a natural sign of progression in the industry and a big step forward for patients seeking access to a variety of diverse products," said Mark Zekulin, President of Tweed. "Tweed has the largest growing facilities in the country, and is ready to move expeditiously to offer its customers a diverse line of oil extracts."